Countries World
Gilgamesh's lead asset, bretisilocin (GM-2505), is a potential best-in-class psychedelic compound currently in Phase 2 development for the treatment of m...
August 26, 2025 | News
Esaote – one of the world's leading medical imaging companies - is proud to announce that the MyLab™ A50 and MyLab™ A...
August 25, 2025 | News
Piramal Pharma Solutions, a global leader in contract development and manufacturing (CDMO) and part of Piramal Pharma Ltd. (NSE: PPLPHARMA) (BSE: 543635), ...
August 25, 2025 | News
Thermo Fisher Scientific Inc., the world leader in serving science, announced the grand opening of its innovative manufacturing center of excellence ...
August 22, 2025 | News
XtalPi announced on the 20th that it signed a Memorandum of Understanding (MOU) with Korea's leading pharmaceutical company Dong-A ST, to jointl...
August 21, 2025 | News
LSPedia, a leading provider of pharmaceutical compliance, serialization, and supply chain software solutions, today announced a strategic partnership with ...
August 21, 2025 | News
Thermo Fisher Scientific has introduced the Gibco™ Expi293™ PRO Expression System, a next-generation HEK293 transient expression system designe...
August 20, 2025 | News
LabConnect, LLC, a global leader in central laboratory services for clinical trials, announced the launch of LabConnector™, a powerful new techn...
August 20, 2025 | News
This innovative platform technology, with exceptional scalability, has been recognized as highly valuable even with limited rights granted. DXVX is taki...
August 19, 2025 | News
Anixa Biosciences, Inc. a biotechnology company focused on the treatment and prevention of cancer, announced that the second patient in th...
August 19, 2025 | News
IQVIA and Veeva Systems announced global clinical and commercial partnerships and the complete resolution of all pending legal disputes. Und...
August 19, 2025 | News
GenScript Biotech Corporation (HK.1548), a global pioneer in life sciences innovation, today announced outstanding interim results for the first half of 20...
August 18, 2025 | Company results
SineuGene Therapeutics Co., Ltd. ("SineuGene"), clinical-stage biotechnology company that mainly focuses on gene therapies for neurological disorders, anno...
August 18, 2025 | News
Collaboration focused on undisclosed GPCR targets Company to receive an upfront and near-term payments, including an equity investment, as...
August 15, 2025 | News
Most Read
Bio Jobs
News
Editor Picks